Results 11 to 20 of about 178,635,816 (158)
Cervical metastasis of esophagogastric junction cancer
Indian Journal of Pathology and Microbiology, 2012 As cervical metastases in esophagogastric junction cancer are extremely rare, the authors herein report a case. A 63-year-old woman presented with dysphagia since 6 months.
Zhiqiang Cai +3 more
doaj +2 more sources
Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction [PDF]
World Journal of Surgical Oncology, 2012 Background The epidermal growth factor receptor (EGFR) inhibitor, gefitinib, has been reported to successfully treat advanced non-small cell lung cancer patients with genetic mutations in EGFR.
Wang Wen-Ping +3 more
doaj +2 more sources
Indian Journal of Pathology and Microbiology, 2012 The simultaneous occurrence of two primary tumors in one patient is not uncommon, but one tumor metastasizing to another malignancy is a rare phenomenon. Tumor-to-tumor metastasis was first described by Berent in 1902.
Renu Sukumaran +3 more
doaj +2 more sources
Mixed adenoneuroendocrine carcinoma of the esophagogastric junction: a case report
Surgical Case Reports, 2018 Background Mixed adenoneuroendocrine carcinoma (MANEC) is a tumor of the gastrointestinal tract that contains both exocrine and endocrine components, with each component exceeding 30% of the total tumor area.
Miho Yamamoto +7 more
doaj +2 more sources
Open Medicine, 2016 Although the Hox transcript antisense intergenic RNA (HOTAIR), a vital long non-coding RNA, is known to participate in the development and progression of a wide range of carcinomas, there are still no published reports regarding its expression in ...
Hui Zhang, Xianglin Meng
doaj +2 more sources
The study of molecular markers for the progression of Barrett's Oesophagus to adenocarcinoma to identify markers that can be used as diagnostic tools. [PDF]
, 2002 Barrett's oesophagus is a complication of gastro-oesophageal reflux disease and is the single most important predisposing factor for the development of adenocarcinoma of the oesophagus.
Cadd, Verity Anne
core +7 more sources
Analysis of N6-Methyladenosine Methylome in Adenocarcinoma of Esophagogastric Junction
Frontiers in Genetics, 2022 Background: From previous studies, we found that there are more than 100 types of RNA modifications in RNA molecules. m6A methylation is the most common.
Jia-Bin Huang +6 more
doaj +1 more source
Integrative proteomic characterization of adenocarcinoma of esophagogastric junction
Nature Communications, 2023 The molecular subtypes of adenocarcinoma of the esophagogastric junction (AEG) remain to be identified. Here, the authors perform proteogenomic characterisation of AEG tumours with paired normal adjacent tissues and suggest three proteomic subtypes and ...
Shengli Li +18 more
doaj +1 more source
Clinical and prognostic features of MMP-2 and VEGF in AEG patients
Open Medicine, 2021 Adenocarcinoma of the esophagogastric junction (AEG) has been increased in recent years and has become a worldwide problem that seriously affects human health.
Zheng Qing-Kang +3 more
doaj +1 more source
Surgical Case Reports, 2020 Background Patients with esophagogastric junction cancer are increasing in Western and Eastern countries. Conversely, the clinical significance of surgical resection remains controversial in these patients.
Takako Tanaka +15 more
doaj +1 more source